This forum is for the discussion of anything to do with Prostate Cancer. There are only four rules:
No fundraisers, no commercials (although it is OK to recommend choices of treatment or medical people based on your personal research; invitations to participate in third-party surveys are also acceptable, provided there is no compensation to YANA);
No harvesting e-mail addresses for Spam;
No insults or flaming - be polite and respectful at all times and understand that there may be a variety of points of view, all of which may have some validity;
Opinions are OK, but please provide as much factual evidence as possible for any assertions that you are making
Failure to abide by these simple rules will result in the immediate and permanent suspension of your posting privileges.
Since this is an International Forum, please specify your location in your post.
Mark Hirst is an undergraduate student working with McMaster University and Population Health Research Institute. He is working on a study to uncover clinician and prostate cancer patient's awareness of, and clinical actions resulting from the knowledge of androgen deprivation therapy resulting in a higher risk for developing cardiovascular disease.
His team prepared a survey for patients who have or previously had prostate cancer to understand their experience through treatment in order to minimize this relationship between treatment and cardiovascular disease:
Participation in this survey is completely optional, but anything that helps to improve awareness of Prostate Cancer treatment options and side-effects is worthwhile.
Irvine, California (USA)